Infectious Disease Diagnostic Testing: World Market Analysis


Attention: There is an updated edition available for this report.

Infectious Disease Diagnostic Testing: World Market Analysis

Infectious disease testing comprises one of the largest and fastest growing applications served by the global in vitro diagnostics (IVD) industry. Infectious diseases are ailments caused by pathogenic microorganisms that invade the body, either directly or indirectly via afflicted carriers or contaminated sources. IVD tests for these conditions are designed to detect and identify the responsible pathogen, pinpoint its origin, and determine an appropriate antimicrobial therapy.

Infectious disease IVD products include reagents, consumables, and instruments based primarily on immunoassays, molecular technologies, and conventional microbiology techniques. Specific types of tests are available for detecting hundreds of pathogenic conditions. The report examines the global demand for infectious disease IVD products, which is projected to increase as medical providers and healthcare organizations throughout the world heighten efforts to combat proliferating epidemic threats.

This report, Infectious Disease Diagnostic Testing: World Market Analysis, examines the global market for infectious disease testing products. Specific applications analyzed include:

  • Healthcare-associated and opportunistic infections
  • Antimicrobial-resistant pathogens including bacteria, fungi, parasites, and viruses
  • Human immunodeficiency virus (HIV) and hepatitis viruses
  • Diseases related to women’s health and sexually transmitted infections (STDs)
  • Emerging, neglected, and tropical disease threats
  • Respiratory tract infections and respiratory viruses (including COVID-19)
Geographic and Country Markets

Opportunities for infectious disease testing products vary widely between the developed and developing countries. Regions covered include:
  • North America
  • Eastern Europe
  • Western Europe
  • Asia/Pacific
  • Africa/Middle East
  • Central and South America
  • Other Regions
Market Drivers

The report examines market drivers, including external market influences that are promoting the development and use of improved infectious disease diagnostics. Public health officials worldwide have begun to recognize the global nature of infectious diseases – they are no longer solely a problem of developing countries but touch the very fabric of the social and economic welfare of countries in the industrialized world as well. Over the long term, aging populations and problems posed by infectious diseases will strain healthcare resources in many countries.

Competitive Landscape

The report details the major competitors that are global market leaders in infectious disease testing products and technologies, including an overview and an outline of these company's infectious disease IVD products:
  • Abbott Laboratories
  • Becton, Dickinson and Company (BD)
  • bioMérieux Inc.
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • DiaSorin S.p.A.
  • Grifols
  • Hologic, Inc.
  • Ortho-Clinical Diagnostics
  • QIAGEN N.V.
  • Quidel Corporation
  • Roche
  • Siemens AG
  • Thermo Fisher Scientific Inc.
The information presented herein is derived from publicly available information sources such as company, government, and medical organization reports. The analysis is based on the author's industry knowledge combined with literature searches and selected direct interviews with industry experts conducted previously.

Estimates in the report are based on an examination of epidemiological statistics, test pricing, annual reports of key competitors and regional sales, as well as Kalorama Information’s databases and economic composites. Forecasts presented for Eastern Europe were prepared prior to Russia’s invasion of Ukraine and its negative impact on the healthcare systems of both countries.


  • Executive Summary
    • A Mix of Traditional and Emerging Testing Technologies
    • Market Drivers
    • The World Infectious Disease Testing Market
      • Table World Infectious Disease Diagnostic Test Market, 2018-2026 ($ millions)
      • Table World Infectious Disease Diagnostic Test Market, 2027-2031 ($ millions)
    • Major Findings of the Report
      • Table Selected Infectious Diseases, Global Incidence, Prevalence, &Mortality, 2021
    • Scope and Methodology
  • Market Environment
    • Overview
    • Population
      • Table Population by Country, 2018-2025 (million)
      • Table Population by Country, 2026-2031 (million)
    • Age Distribution
      • Table Population 50 Years & Older by Country, 2018-2025 (million)
      • Table Population 50 Years & Older by Country, 2026-2031 (million)
      • Table Population 65 Years & Older by Country, 2018-2025 (million)
      • Table Population 65 Years & Older by Country, 2026-2031 (million)
    • Macroeconomic Environment
      • Global Economic Outlook
        • Table Gross Domestic Product by Country, 2018-2025 (billion dollars)
        • Table Gross Domestic Product by Country, 2026-2031 (billion dollars)
      • Per Capita Gross Domestic Product
        • Table Per Capita Gross Domestic Product by Country, 2018-2025 (dollars)
        • Table Per Capita Gross Domestic Product by Country, 2026-2031 (dollars)
    • Global Healthcare Trends
      • Infectious Disease Cases
        • Table Number of Infectious Disease Cases by Country, 2018-2025 (million)
        • Table Number of Infectious Disease Cases by Country, 2026-2031 (million)
        • Table Health Expenditures by Country, 2018-2025 (billion dollars)
        • Table Health Expenditures by Country, 2026-2031 (billion dollars)
      • Medical Providers
        • Table Medical Providers, Selected Countries, 2021
      • Patient Activity
        • Table Hospital Admissions by Country, 2018-2025 (million)
        • Table Hospital Admissions by Country, 2026-2031 (million)
        • Table Inpatient Days by Country, 2018-2025 (million)
        • Table Inpatient Days by Country, 2026-2031 (million)
        • Table Surgical Procedures by Country, 2018-2025 (million)
        • Table Surgical Procedures by Country, 2026-2031 (million)
        • Table Outpatient Consultations by Country, 2018-2025 (million)
        • Table Outpatient Consultations by Country, 2026-2031 (million)
        • Table IVD Tests by Country, 2018-2025 (million)
        • Table IVD Tests by Country, 2026-2031 (million)
  • Infectious Disease IVD Products & Markets
    • Overview
      • Table Global Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
      • Table Global Infectious Disease IVD Products Demand by Type, 2026-2031 (million dollars)
    • Sexually Transmitted Infections (STIs)
      • Table Global Sexually Transmitted Infection IVD Products Demand, 2018-2025 (million dollars)
      • Table Global Sexually Transmitted Infections IVD Products Demand, 2026-2031 (million dollars)
      • Chlamydia Trachomatis (chlamydia)
      • Human Papillomavirus (HPV)
      • Gonorrhea
      • Herpes Simplex Virus 2 (HSV-2)
      • Syphilis
      • Other Sexually Transmitted Disease (STD) IVD Products
    • Healthcare-Associated Infections
      • Table Global Healthcare-Associated Infection IVD Products Demand, 2018-2025 (million dollars)
      • Table Global Healthcare-Associated Infections IVD Products Demand, 2026-2031 (million dollars)
      • Clostridium difficile (C. diff)
      • Sepsis
      • Methicillin-Resistant Staphylococcus Aureus (MRSA)
      • Vancomycin-Resistant Enterococcus (VRE)
      • Other HAIs
    • Identification & Antibiotic Susceptibility Testing (ID/AST) Products
      • Table Global ID/AST IVD Products Demand, 2018-2025 (million dollars)
      • Table Global ID/AST IVD Products Demand, 2026-2031 (million dollars)
      • Automated ID/AST Products
      • Manual Panels & Reagents
      • Producers
    • Hepatitis IVD Products
      • Table Global Hepatitis IVD Products Demand, 2018-2025 (million dollars)
      • Table Global Hepatitis IVD Products Demand, 2026-2031 (million dollars)
    • HIV/AIDS IVD Products
      • Table Global HIV/AIDS IVD Products Demand, 2018-2025 (million dollars)
      • Table Global HIV/AIDS IVD Products Demand, 2026-2031 (million dollars)
    • Influenza
      • Table Global Influenza IVD Products Demand, 2018-2025 (million dollars)
      • Table Global Influenza IVD Products Demand, 2026-2031 (million dollars)
    • Tuberculosis (TB)
      • Table Global Tuberculosis IVD Products Demand, 2018-2025 (million dollars)
      • Table Global Tuberculosis IVD Products Demand, 2026-2031 (million dollars)
    • TORCH
      • Table Global TORCH IVD Products Demand, 2018-2025 (million dollars)
      • Table Global TORCH IVD Products Demand, 2026-2031 (million dollars)
    • All Other Infectious Disease IVD Products
      • Table Global Other Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
      • Table Global Other Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
      • Malaria
      • Streptococcal Infections
      • Fungal Infections
      • Parasitic Conditions
      • Lyme Disease
      • Respiratory Syncytial Virus (RSV)
      • Emerging Infections
      • Chikungunya
      • Dengue Fever
      • Additional Products
    • COVID-19
      • Table Global COVID-19 IVD Products Demand, 2018-2026 (million dollars)
    • Global Infectious Disease IVD Technologies
      • Table Global Infectious Disease IVD Products Demand by Technology, 2018-2025 (million dollars)
      • Table Global Infectious Disease IVD Products Demand by Technology, 2026-2031 (million dollars)
      • Immunoassays
        • Table Global Immunoassay Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
        • Table Global Immunoassay Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
      • Molecular Technologies
        • Table Global Molecular Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
        • Table Global Molecular Infectious Disease IVD Products Demand 2026-2031 (million dollars)
      • Conventional Microbiology
        • Table Global Microbiology Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
        • Table Global Microbiology Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
    • Global Infectious Disease IVD Demand by Market
      • Table Global Infectious Disease IVD Products Demand by Site, 2018-2025 (million dollars)
      • Table Global Infectious Disease IVD Products Demand by Site, 2026-2031 (million dollars)
      • Table Global Laboratory Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
      • Table Global Laboratory Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
      • Table Global Point-of-Care Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
      • Table Global Point-of-Care Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
  • Global Markets
    • Overview
      • Table Infectious Disease IVD Products Demand by Country, 2018-2025 (million dollars)
      • Table Infectious Disease IVD Products Demand by Country/Region, 2026-2031 (million dollars)
    • North America
      • Table North America: Infectious Disease IVD Products Demand, 2018-2025 (million dollars)
      • Table North America: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
      • United States
        • Table United States: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
        • Table United States: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
      • Canada
        • Table Canada: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
        • Table Canada: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
      • Mexico
        • Table Mexico: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
        • Table Mexico: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
    • Western Europe
      • Table Western Europe: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
      • Table Western Europe: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
      • Germany
        • Table Germany: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
        • Table Germany: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
      • France
        • Table France: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
        • Table France: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
      • United Kingdom
        • Table United Kingdom: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
        • Table United Kingdom: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
      • Italy
        • Table Italy: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
        • Table Italy: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
      • Spain
        • Table Spain: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
        • Table Spain: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
      • Other Western Europe
        • Table Other Western Europe: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
        • Table Other Western Europe: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
    • Asia/Pacific
      • Table Asia/Pacific: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
      • Table Asia/Pacific: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
      • China
        • Table China: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
        • Table China: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
      • India
        • Table India: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
        • Table India: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
      • Japan
        • Table Japan: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
        • Table Japan: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
      • South Korea
        • Table South Korea: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
        • Table South Korea: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
      • Other Asia/Pacific
        • Table Other Asia/Pacific: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
        • Table Other Asia/Pacific: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
    • Other Regions
      • Table Other Regions: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
      • Table Other Regions: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
    • Central & South America
      • Table Central & South America: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
      • Table Central & South America: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
      • Brazil
      • Argentina
      • Colombia
      • Peru
      • Chile
      • All Other Countries & Territories
    • Eastern Europe
      • Table Eastern Europe: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
      • Table Eastern Europe: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
      • Russia
      • Poland
      • Romania
      • Czech Republic
      • Hungary
      • All Other Countries
    • Africa/Middle East
      • Table Africa/Middle East: Infectious Disease IVD Products Demand by Type, 2018-2025 (million dollars)
      • Table Africa/Middle East: Infectious Disease IVD Products Demand, 2026-2031 (million dollars)
      • Turkey
      • Saudi Arabia
      • Iran
      • Egypt
      • Iraq
      • Nigeria
      • South Africa
      • Israel
      • United Arab Emirates
      • All Other Countries & Territories
  • Company Profiles
    • Abbott Laboratories
    • Becton Dickinson and Company
    • Bio-Rad Laboratories
    • bioMérieux
    • Bruker Corporation
    • Danaher Corporation
    • DiaSorin
    • Grifols S.A.
    • Hologic
    • Ortho Clinical Diagnostics Holdings
    • QIAGEN
    • Quidel Corporation
    • Roche Holding
      • Immunoassays
      • COVID-19
    • Siemens Healthineers
    • Thermo Fisher Scientific
      • Microbiology
      • COVID-19

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings